Rory O'Driscoll
CIK 1366969 · last filed 2022-12-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BOX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 700
FOSTER CITY, CA 94404
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BILL | Director | 6,826 | $49.68 | $339.1K | -$71.02M | 16 | 2022-12-12 |
| BOX | Director | 54,726 | $42.60 | $2.33M | -$124.67M | 26 | 2019-06-21 |
| DOCU | Director | 4,741,814 | $84.71 | $401.68M | -$14.07M | 1 | 2018-05-02 |
| ALIMERA SCIENCES INC (ALIM) Delisted | 10%+ Owner | 299,202 | $5.54 | $1.66M | $18.19M | 4 | 2015-04-23 |
| ET | Director | 23,064 | $20.11 | $463.7K | -$47.99M | 11 | 2013-07-12 |
Recent Filings · Page 6 of 11
109 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-02-28 | ET | Grant (A) | +6,108 | $0 | EDGAR |
| 2012-12-21 | ET | Sell (S) | −93,400 | -$1.87M | EDGAR |
| 2012-12-20 | ET | Sell (S) | −336,500 | -$6.49M | EDGAR |
| 2012-12-17 | ET | Sell (S) | −370,100 | -$6.76M | EDGAR |
| 2012-09-18 | ET | Sell (S) | −1,049,427 | -$23.61M | EDGAR |
| 2012-04-18 | ET | Grant (A) | +5,766 | $0 | EDGAR |
| 2012-03-29 | ET | Conv (C) | +3,932,362 | $0 | EDGAR |
| 2010-04-28 | ALIMERA SCIENCES INC (ALIM) Delisted | Mixed | +24,315,470 | $20.00M | EDGAR |
| 2009-10-27 | — | Mixed | −1,750,953 | -$37.65M | |
| 2009-05-27 | — | Grant (A) | — | $0 |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.